new BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 1101 hits with Last Name = 'hughes' and Initial = 'ad'   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM50337878
PNG
((R)-1-(9-(2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydro...)
Show SMILES O[C@@H](CNCCCCCCCCCN1CCC(CC1)OC(=O)Nc1ccccc1-c1ccccc1)c1ccc(O)c2[nH]c(=O)ccc12 |r|
Show InChI InChI=1S/C38H48N4O5/c43-34-19-17-31(32-18-20-36(45)41-37(32)34)35(44)27-39-23-11-4-2-1-3-5-12-24-42-25-21-29(22-26-42)47-38(46)40-33-16-10-9-15-30(33)28-13-7-6-8-14-28/h6-10,13-20,29,35,39,43-44H,1-5,11-12,21-27H2,(H,40,46)(H,41,45)/t35-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Patents

Article
PubMed
0.0100n/an/an/an/an/an/an/an/a



Theravance, Inc.

Curated by ChEMBL


Assay Description
Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay


Bioorg Med Chem Lett 21: 1354-8 (2011)

Checked by Author
Article DOI: 10.1016/j.bmcl.2011.01.043
BindingDB Entry DOI: 10.7270/Q2NC61HQ
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM50296345
PNG
((1R,2R,4S,5R,7S)-7-(2-hydroxy-2,2-di-thiophen-2-yl...)
Show SMILES C[N+]1(C)[C@@H]2C[C@H](C[C@@H]1[C@@H]1O[C@H]21)OC(=O)C(O)(c1cccs1)c1cccs1 |TLB:11:5:1:8.10|
Show InChI InChI=1S/C19H22NO4S2/c1-20(2)12-9-11(10-13(20)17-16(12)24-17)23-18(21)19(22,14-5-3-7-25-14)15-6-4-8-26-15/h3-8,11-13,16-17,22H,9-10H2,1-2H3/q+1/t11-,12-,13-,16-,17+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
Purchase

CHEMBL
PC cid
PC sid
UniChem
Article
PubMed
0.0316n/an/an/an/an/an/an/an/a



Theravance Biopharma, Inc.

Curated by ChEMBL


Assay Description
Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting


J Med Chem 58: 2609-22 (2015)


Article DOI: 10.1021/jm501915g
BindingDB Entry DOI: 10.7270/Q2N29ZNQ
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM50296345
PNG
((1R,2R,4S,5R,7S)-7-(2-hydroxy-2,2-di-thiophen-2-yl...)
Show SMILES C[N+]1(C)[C@@H]2C[C@H](C[C@@H]1[C@@H]1O[C@H]21)OC(=O)C(O)(c1cccs1)c1cccs1 |TLB:11:5:1:8.10|
Show InChI InChI=1S/C19H22NO4S2/c1-20(2)12-9-11(10-13(20)17-16(12)24-17)23-18(21)19(22,14-5-3-7-25-14)15-6-4-8-26-15/h3-8,11-13,16-17,22H,9-10H2,1-2H3/q+1/t11-,12-,13-,16-,17+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
Purchase

CHEMBL
PC cid
PC sid
UniChem
Article
PubMed
0.0340n/an/an/an/an/an/an/an/a



Theravance, Inc.

Curated by ChEMBL


Assay Description
Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay


Bioorg Med Chem Lett 21: 1354-8 (2011)

Checked by Author
Article DOI: 10.1016/j.bmcl.2011.01.043
BindingDB Entry DOI: 10.7270/Q2NC61HQ
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM50084436
PNG
(CHEMBL3426693)
Show SMILES Cc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1NC(=O)CCN1CCC(CC1)OC(=O)Nc1ccccc1-c1ccccc1 |r|
Show InChI InChI=1/C40H43N5O6/c1-26-23-27(24-41-25-36(47)31-12-15-35(46)39-32(31)13-16-37(48)44-39)11-14-33(26)42-38(49)19-22-45-20-17-29(18-21-45)51-40(50)43-34-10-6-5-9-30(34)28-7-3-2-4-8-28/h2-16,23,29,36,41,46-47H,17-22,24-25H2,1H3,(H,42,49)(H,43,50)(H,44,48)/t36-/s2
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
Article
PubMed
0.0501n/an/an/an/an/an/an/an/a



Theravance Biopharma, Inc.

Curated by ChEMBL


Assay Description
Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting


J Med Chem 58: 2609-22 (2015)


Article DOI: 10.1021/jm501915g
BindingDB Entry DOI: 10.7270/Q2N29ZNQ
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM50084443
PNG
(CHEMBL3426687)
Show SMILES O[C@@H](CNCc1ccc(NC(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)cc1)c1ccc(O)c2[nH]c(=O)ccc12 |r|
Show InChI InChI=1/C39H41N5O6/c45-34-16-14-31(32-15-17-36(47)43-38(32)34)35(46)25-40-24-26-10-12-28(13-11-26)41-37(48)20-23-44-21-18-29(19-22-44)50-39(49)42-33-9-5-4-8-30(33)27-6-2-1-3-7-27/h1-17,29,35,40,45-46H,18-25H2,(H,41,48)(H,42,49)(H,43,47)/t35-/s2
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
Article
PubMed
0.0794n/an/an/an/an/an/an/an/a



Theravance Biopharma, Inc.

Curated by ChEMBL


Assay Description
Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting


J Med Chem 58: 2609-22 (2015)


Article DOI: 10.1021/jm501915g
BindingDB Entry DOI: 10.7270/Q2N29ZNQ
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103742
PNG
(US8551978, I-6 | US8816088, I-6 | US9394275, I-6 |...)
Show SMILES COc1cc(NC(=O)CCCN(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r|
Show InChI InChI=1S/C45H51ClN6O8/c1-51(43(57)20-24-52-22-18-31(19-23-52)60-45(58)49-36-12-7-6-11-32(36)29-9-4-3-5-10-29)21-8-13-41(55)48-37-26-40(59-2)30(25-35(37)46)27-47-28-39(54)33-14-16-38(53)44-34(33)15-17-42(56)50-44/h3-7,9-12,14-17,25-26,31,39,47,53-54H,8,13,18-24,27-28H2,1-2H3,(H,48,55)(H,49,58)(H,50,56)/t39-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company LLC

US Patent




US Patent US9572802 (2017)


BindingDB Entry DOI: 10.7270/Q2VH5QWS
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM143688
PNG
(US9572802, Compound I-7 | US9682957, I-7)
Show SMILES CN(CCCC(=O)Nc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)c1)C(=O)CCN1CCC(CC1)OC(=O)Nc1ccccc1-c1ccccc1 |r|
Show InChI InChI=1/C45H52N6O7/c1-50(43(56)23-28-51-26-21-34(22-27-51)58-45(57)48-38-14-6-5-13-35(38)32-10-3-2-4-11-32)25-8-15-41(54)47-33-12-7-9-31(29-33)20-24-46-30-40(53)36-16-18-39(52)44-37(36)17-19-42(55)49-44/h2-7,9-14,16-19,29,34,40,46,52-53H,8,15,20-28,30H2,1H3,(H,47,54)(H,48,57)(H,49,55)/t40-/s2
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company LLC

US Patent




US Patent US9572802 (2017)


BindingDB Entry DOI: 10.7270/Q2VH5QWS
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM38242
PNG
(US8551978, I-7 | US8551978, I-8 | US9394275, I-8 |...)
Show SMILES CN(CCCC(=O)Nc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1)C(=O)CCN1CCC(CC1)OC(=O)Nc1ccccc1-c1ccccc1 |r|
Show InChI InChI=1S/C45H52N6O7/c1-50(43(56)24-29-51-27-22-34(23-28-51)58-45(57)48-38-11-6-5-10-35(38)32-8-3-2-4-9-32)26-7-12-41(54)47-33-15-13-31(14-16-33)21-25-46-30-40(53)36-17-19-39(52)44-37(36)18-20-42(55)49-44/h2-6,8-11,13-20,34,40,46,52-53H,7,12,21-30H2,1H3,(H,47,54)(H,48,57)(H,49,55)/t40-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company LLC

US Patent




US Patent US9572802 (2017)


BindingDB Entry DOI: 10.7270/Q2VH5QWS
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103744
PNG
(US8551978, I-9 | US8816088, I-9 | US9394275, I-9 |...)
Show SMILES COc1ccc(NC(=O)CCCN(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)cc1CCNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r|
Show InChI InChI=1S/C46H54N6O8/c1-51(44(57)23-28-52-26-21-34(22-27-52)60-46(58)49-38-12-7-6-11-35(38)31-9-4-3-5-10-31)25-8-13-42(55)48-33-14-18-41(59-2)32(29-33)20-24-47-30-40(54)36-15-17-39(53)45-37(36)16-19-43(56)50-45/h3-7,9-12,14-19,29,34,40,47,53-54H,8,13,20-28,30H2,1-2H3,(H,48,55)(H,49,58)(H,50,56)/t40-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company LLC

US Patent




US Patent US9572802 (2017)


BindingDB Entry DOI: 10.7270/Q2VH5QWS
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103745
PNG
(US8551978, I-10 | US8816088, I-10 | US9394275, I-1...)
Show SMILES CC(Cc1cccc(NC(=O)CCCN(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r|
Show InChI InChI=1S/C46H54N6O7/c1-31(47-30-41(54)37-17-19-40(53)45-38(37)18-20-43(56)50-45)28-32-10-8-13-34(29-32)48-42(55)16-9-24-51(2)44(57)23-27-52-25-21-35(22-26-52)59-46(58)49-39-15-7-6-14-36(39)33-11-4-3-5-12-33/h3-8,10-15,17-20,29,31,35,41,47,53-54H,9,16,21-28,30H2,1-2H3,(H,48,55)(H,49,58)(H,50,56)/t31?,41-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company LLC

US Patent




US Patent US9572802 (2017)


BindingDB Entry DOI: 10.7270/Q2VH5QWS
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103746
PNG
(US8551978, I-11 | US8816088, I-11 | US9394275, I-1...)
Show SMILES CC(Cc1cccc(CC(=O)NCCCN(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r|
Show InChI InChI=1S/C47H56N6O7/c1-32(49-31-42(55)38-16-18-41(54)46-39(38)17-19-43(56)51-46)28-33-10-8-11-34(29-33)30-44(57)48-23-9-24-52(2)45(58)22-27-53-25-20-36(21-26-53)60-47(59)50-40-15-7-6-14-37(40)35-12-4-3-5-13-35/h3-8,10-19,29,32,36,42,49,54-55H,9,20-28,30-31H2,1-2H3,(H,48,57)(H,50,59)(H,51,56)/t32?,42-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company LLC

US Patent




US Patent US9572802 (2017)


BindingDB Entry DOI: 10.7270/Q2VH5QWS
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103747
PNG
(US8551978, I-12 | US8816088, I-12 | US9394275, I-1...)
Show SMILES C[C@H](Cc1cccc(CC(=O)NCCCN(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r|
Show InChI InChI=1S/C47H56N6O7/c1-32(49-31-42(55)38-16-18-41(54)46-39(38)17-19-43(56)51-46)28-33-10-8-11-34(29-33)30-44(57)48-23-9-24-52(2)45(58)22-27-53-25-20-36(21-26-53)60-47(59)50-40-15-7-6-14-37(40)35-12-4-3-5-13-35/h3-8,10-19,29,32,36,42,49,54-55H,9,20-28,30-31H2,1-2H3,(H,48,57)(H,50,59)(H,51,56)/t32-,42+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company LLC

US Patent




US Patent US9572802 (2017)


BindingDB Entry DOI: 10.7270/Q2VH5QWS
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM238344
PNG
(US9394275, I-13 | US9572802, Compound I-13 | US968...)
Show SMILES C[C@@H](Cc1cccc(CC(=O)NCCCN(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
Show InChI InChI=1S/C47H56N6O7/c1-32(49-31-42(55)38-16-18-41(54)46-39(38)17-19-43(56)51-46)28-33-10-8-11-34(29-33)30-44(57)48-23-9-24-52(2)45(58)22-27-53-25-20-36(21-26-53)60-47(59)50-40-15-7-6-14-37(40)35-12-4-3-5-13-35/h3-8,10-19,29,32,36,42,49,54-55H,9,20-28,30-31H2,1-2H3,(H,48,57)(H,50,59)(H,51,56)/t32-,42-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company LLC

US Patent




US Patent US9572802 (2017)


BindingDB Entry DOI: 10.7270/Q2VH5QWS
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM6384
PNG
(US8551978, I-14 | US8816088, 14 | US8816088, I-15 ...)
Show SMILES CN(CCCCC(=O)Nc1ccc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1)C(=O)CCN1CCC(CC1)OC(=O)Nc1ccccc1-c1ccccc1 |r|
Show InChI InChI=1S/C45H52N6O7/c1-50(43(56)24-28-51-26-22-34(23-27-51)58-45(57)48-38-12-6-5-11-35(38)32-9-3-2-4-10-32)25-8-7-13-41(54)47-33-16-14-31(15-17-33)29-46-30-40(53)36-18-20-39(52)44-37(36)19-21-42(55)49-44/h2-6,9-12,14-21,34,40,46,52-53H,7-8,13,22-30H2,1H3,(H,47,54)(H,48,57)(H,49,55)/t40-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company LLC

US Patent




US Patent US9572802 (2017)


BindingDB Entry DOI: 10.7270/Q2VH5QWS
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103748
PNG
(US8551978, I-15 | US9394275, I-15 | US9572802, Com...)
Show SMILES CN(CCCCC(=O)Nc1ccc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1C)C(=O)CCN1CCC(CC1)OC(=O)Nc1ccccc1-c1ccccc1 |r|
Show InChI InChI=1S/C46H54N6O7/c1-31-28-32(29-47-30-41(54)36-16-19-40(53)45-37(36)17-20-43(56)50-45)15-18-38(31)48-42(55)14-8-9-24-51(2)44(57)23-27-52-25-21-34(22-26-52)59-46(58)49-39-13-7-6-12-35(39)33-10-4-3-5-11-33/h3-7,10-13,15-20,28,34,41,47,53-54H,8-9,14,21-27,29-30H2,1-2H3,(H,48,55)(H,49,58)(H,50,56)/t41-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company LLC

US Patent




US Patent US9572802 (2017)


BindingDB Entry DOI: 10.7270/Q2VH5QWS
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103749
PNG
(US8551978, I-16 | US8816088, I-16 | US9394275, I-1...)
Show SMILES COc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1NC(=O)CCCCN(C)C(=O)CCN1CCC(CC1)OC(=O)Nc1ccccc1-c1ccccc1 |r|
Show InChI InChI=1S/C46H54N6O8/c1-51(44(57)23-27-52-25-21-33(22-26-52)60-46(58)49-37-13-7-6-12-34(37)32-10-4-3-5-11-32)24-9-8-14-42(55)48-38-18-15-31(28-41(38)59-2)29-47-30-40(54)35-16-19-39(53)45-36(35)17-20-43(56)50-45/h3-7,10-13,15-20,28,33,40,47,53-54H,8-9,14,21-27,29-30H2,1-2H3,(H,48,55)(H,49,58)(H,50,56)/t40-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company LLC

US Patent




US Patent US9572802 (2017)


BindingDB Entry DOI: 10.7270/Q2VH5QWS
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103750
PNG
(US8551978, I-17 | US8816088, I-17 | US9394275, I-1...)
Show SMILES COc1cc(NC(=O)CCCCN(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)ccc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r|
Show InChI InChI=1S/C46H54N6O8/c1-51(44(57)23-27-52-25-21-34(22-26-52)60-46(58)49-38-13-7-6-12-35(38)31-10-4-3-5-11-31)24-9-8-14-42(55)48-33-16-15-32(41(28-33)59-2)29-47-30-40(54)36-17-19-39(53)45-37(36)18-20-43(56)50-45/h3-7,10-13,15-20,28,34,40,47,53-54H,8-9,14,21-27,29-30H2,1-2H3,(H,48,55)(H,49,58)(H,50,56)/t40-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company LLC

US Patent




US Patent US9572802 (2017)


BindingDB Entry DOI: 10.7270/Q2VH5QWS
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM6387
PNG
(US8816088, 18 | US9394275, I-18 | US9572802, Compo...)
Show SMILES CN(CCCCC(=O)Nc1cc(C)c(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1C)C(=O)CCN1CCC(CC1)OC(=O)Nc1ccccc1-c1ccccc1 |r|
Show InChI InChI=1S/C47H56N6O7/c1-31-28-40(32(2)27-34(31)29-48-30-42(55)37-16-18-41(54)46-38(37)17-19-44(57)51-46)49-43(56)15-9-10-23-52(3)45(58)22-26-53-24-20-35(21-25-53)60-47(59)50-39-14-8-7-13-36(39)33-11-5-4-6-12-33/h4-8,11-14,16-19,27-28,35,42,48,54-55H,9-10,15,20-26,29-30H2,1-3H3,(H,49,56)(H,50,59)(H,51,57)/t42-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company LLC

US Patent




US Patent US9572802 (2017)


BindingDB Entry DOI: 10.7270/Q2VH5QWS
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103751
PNG
(US8551978, I-19 | US8816088, I-19 | US9394275, I-1...)
Show SMILES COc1cc(NC(=O)CCCCN(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r|
Show InChI InChI=1S/C46H53ClN6O8/c1-52(44(58)21-25-53-23-19-32(20-24-53)61-46(59)50-37-13-7-6-12-33(37)30-10-4-3-5-11-30)22-9-8-14-42(56)49-38-27-41(60-2)31(26-36(38)47)28-48-29-40(55)34-15-17-39(54)45-35(34)16-18-43(57)51-45/h3-7,10-13,15-18,26-27,32,40,48,54-55H,8-9,14,19-25,28-29H2,1-2H3,(H,49,56)(H,50,59)(H,51,57)/t40-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company LLC

US Patent




US Patent US9572802 (2017)


BindingDB Entry DOI: 10.7270/Q2VH5QWS
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103752
PNG
(US8551978, I-20 | US8816088, I-20 | US9394275, I-2...)
Show SMILES CN(CCCCC(=O)Nc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)c1)C(=O)CCN1CCC(CC1)OC(=O)Nc1ccccc1-c1ccccc1 |r|
Show InChI InChI=1S/C46H54N6O7/c1-51(44(57)24-29-52-27-22-35(23-28-52)59-46(58)49-39-15-6-5-14-36(39)33-11-3-2-4-12-33)26-8-7-16-42(55)48-34-13-9-10-32(30-34)21-25-47-31-41(54)37-17-19-40(53)45-38(37)18-20-43(56)50-45/h2-6,9-15,17-20,30,35,41,47,53-54H,7-8,16,21-29,31H2,1H3,(H,48,55)(H,49,58)(H,50,56)/t41-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company LLC

US Patent




US Patent US9572802 (2017)


BindingDB Entry DOI: 10.7270/Q2VH5QWS
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103753
PNG
(US8551978, I-21 | US8816088, I-21 | US9394275, I-2...)
Show SMILES CN(CCCCC(=O)Nc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1)C(=O)CCN1CCC(CC1)OC(=O)Nc1ccccc1-c1ccccc1 |r|
Show InChI InChI=1S/C46H54N6O7/c1-51(44(57)25-30-52-28-23-35(24-29-52)59-46(58)49-39-12-6-5-11-36(39)33-9-3-2-4-10-33)27-8-7-13-42(55)48-34-16-14-32(15-17-34)22-26-47-31-41(54)37-18-20-40(53)45-38(37)19-21-43(56)50-45/h2-6,9-12,14-21,35,41,47,53-54H,7-8,13,22-31H2,1H3,(H,48,55)(H,49,58)(H,50,56)/t41-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company LLC

US Patent




US Patent US9572802 (2017)


BindingDB Entry DOI: 10.7270/Q2VH5QWS
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103754
PNG
(US8551978, I-22 | US8816088, I-22 | US9394275, I-2...)
Show SMILES CC(Cc1cccc(CC(=O)NCCCCN(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r|
Show InChI InChI=1S/C48H58N6O7/c1-33(50-32-43(56)39-17-19-42(55)47-40(39)18-20-44(57)52-47)29-34-11-10-12-35(30-34)31-45(58)49-24-8-9-25-53(2)46(59)23-28-54-26-21-37(22-27-54)61-48(60)51-41-16-7-6-15-38(41)36-13-4-3-5-14-36/h3-7,10-20,30,33,37,43,50,55-56H,8-9,21-29,31-32H2,1-2H3,(H,49,58)(H,51,60)(H,52,57)/t33?,43-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company LLC

US Patent




US Patent US9572802 (2017)


BindingDB Entry DOI: 10.7270/Q2VH5QWS
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103756
PNG
(US8551978, I-24 | US8816088, I-24 | US9394275, I-2...)
Show SMILES C[C@@H](Cc1cccc(CC(=O)NCCCCN(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r|
Show InChI InChI=1S/C48H58N6O7/c1-33(50-32-43(56)39-17-19-42(55)47-40(39)18-20-44(57)52-47)29-34-11-10-12-35(30-34)31-45(58)49-24-8-9-25-53(2)46(59)23-28-54-26-21-37(22-27-54)61-48(60)51-41-16-7-6-15-38(41)36-13-4-3-5-14-36/h3-7,10-20,30,33,37,43,50,55-56H,8-9,21-29,31-32H2,1-2H3,(H,49,58)(H,51,60)(H,52,57)/t33-,43-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company LLC

US Patent




US Patent US9572802 (2017)


BindingDB Entry DOI: 10.7270/Q2VH5QWS
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103756
PNG
(US8551978, I-24 | US8816088, I-24 | US9394275, I-2...)
Show SMILES C[C@@H](Cc1cccc(CC(=O)NCCCCN(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r|
Show InChI InChI=1S/C48H58N6O7/c1-33(50-32-43(56)39-17-19-42(55)47-40(39)18-20-44(57)52-47)29-34-11-10-12-35(30-34)31-45(58)49-24-8-9-25-53(2)46(59)23-28-54-26-21-37(22-27-54)61-48(60)51-41-16-7-6-15-38(41)36-13-4-3-5-14-36/h3-7,10-20,30,33,37,43,50,55-56H,8-9,21-29,31-32H2,1-2H3,(H,49,58)(H,51,60)(H,52,57)/t33-,43-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company LLC

US Patent




US Patent US9572802 (2017)


BindingDB Entry DOI: 10.7270/Q2VH5QWS
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM6427
PNG
(US8551978, I-25 | US8816088, 25 | US9572802, Compo...)
Show SMILES CN(C(=O)CCN1CCC(CC1)OC(=O)Nc1ccccc1-c1ccccc1)c1cccc(c1)C(=O)Nc1ccc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1 |r|
Show InChI InChI=1S/C47H48N6O7/c1-52(44(57)24-27-53-25-22-36(23-26-53)60-47(59)50-40-13-6-5-12-37(40)32-8-3-2-4-9-32)35-11-7-10-33(28-35)46(58)49-34-16-14-31(15-17-34)29-48-30-42(55)38-18-20-41(54)45-39(38)19-21-43(56)51-45/h2-21,28,36,42,48,54-55H,22-27,29-30H2,1H3,(H,49,58)(H,50,59)(H,51,56)/t42-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company LLC

US Patent




US Patent US9572802 (2017)


BindingDB Entry DOI: 10.7270/Q2VH5QWS
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103758
PNG
(US8551978, I-27 | US8816088, I-27 | US9394275, I-2...)
Show SMILES CN(C(=O)CCN1CCC(CC1)OC(=O)Nc1ccccc1-c1ccccc1)c1cccc(c1)C(=O)Nc1ccc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1C |r|
Show InChI InChI=1S/C48H50N6O7/c1-31-27-32(29-49-30-43(56)38-16-19-42(55)46-39(38)17-20-44(57)52-46)15-18-40(31)50-47(59)34-11-8-12-35(28-34)53(2)45(58)23-26-54-24-21-36(22-25-54)61-48(60)51-41-14-7-6-13-37(41)33-9-4-3-5-10-33/h3-20,27-28,36,43,49,55-56H,21-26,29-30H2,1-2H3,(H,50,59)(H,51,60)(H,52,57)/t43-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company LLC

US Patent




US Patent US9572802 (2017)


BindingDB Entry DOI: 10.7270/Q2VH5QWS
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103760
PNG
(US8551978, I-29 | US8816088, I-29 | US9394275, I-2...)
Show SMILES COc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1NC(=O)c1cccc(c1)N(C)C(=O)CCN1CCC(CC1)OC(=O)Nc1ccccc1-c1ccccc1 |r|
Show InChI InChI=1S/C48H50N6O8/c1-53(45(58)23-26-54-24-21-35(22-25-54)62-48(60)51-39-14-7-6-13-36(39)32-9-4-3-5-10-32)34-12-8-11-33(28-34)47(59)50-40-18-15-31(27-43(40)61-2)29-49-30-42(56)37-16-19-41(55)46-38(37)17-20-44(57)52-46/h3-20,27-28,35,42,49,55-56H,21-26,29-30H2,1-2H3,(H,50,59)(H,51,60)(H,52,57)/t42-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company LLC

US Patent




US Patent US9572802 (2017)


BindingDB Entry DOI: 10.7270/Q2VH5QWS
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103763
PNG
(US8551978, I-32 | US8816088, I-32 | US9394275, I-3...)
Show SMILES CN(C(=O)CCN1CCC(CC1)OC(=O)Nc1ccccc1-c1ccccc1)c1cccc(c1)C(=O)Nc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)c1 |r|
Show InChI InChI=1S/C48H50N6O7/c1-53(45(58)24-28-54-26-22-37(23-27-54)61-48(60)51-41-16-6-5-15-38(41)33-10-3-2-4-11-33)36-14-8-12-34(30-36)47(59)50-35-13-7-9-32(29-35)21-25-49-31-43(56)39-17-19-42(55)46-40(39)18-20-44(57)52-46/h2-20,29-30,37,43,49,55-56H,21-28,31H2,1H3,(H,50,59)(H,51,60)(H,52,57)/t43-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company LLC

US Patent




US Patent US9572802 (2017)


BindingDB Entry DOI: 10.7270/Q2VH5QWS
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM6440
PNG
(BDBM41533 | US8816088, 35 | US9394275, I-34 | US93...)
Show SMILES CN(C(=O)CCN1CCC(CC1)OC(=O)Nc1ccccc1-c1ccccc1)c1cc(ccc1C)C(=O)Nc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1 |r|
Show InChI InChI=1S/C49H52N6O7/c1-32-12-15-35(48(60)51-36-16-13-33(14-17-36)22-26-50-31-44(57)39-18-20-43(56)47-40(39)19-21-45(58)53-47)30-42(32)54(2)46(59)25-29-55-27-23-37(24-28-55)62-49(61)52-41-11-7-6-10-38(41)34-8-4-3-5-9-34/h3-21,30,37,44,50,56-57H,22-29,31H2,1-2H3,(H,51,60)(H,52,61)(H,53,58)/t44-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company LLC

US Patent




US Patent US9572802 (2017)


BindingDB Entry DOI: 10.7270/Q2VH5QWS
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103770
PNG
(US8551978, I-40 | US8816088, I-40 | US9394275, I-4...)
Show SMILES CC(Cc1ccc(NC(=O)c2cccc(c2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r|
Show InChI InChI=1S/C49H52N6O7/c1-32(50-31-44(57)40-19-21-43(56)47-41(40)20-22-45(58)53-47)29-33-15-17-36(18-16-33)51-48(60)35-11-8-12-37(30-35)54(2)46(59)25-28-55-26-23-38(24-27-55)62-49(61)52-42-14-7-6-13-39(42)34-9-4-3-5-10-34/h3-22,30,32,38,44,50,56-57H,23-29,31H2,1-2H3,(H,51,60)(H,52,61)(H,53,58)/t32?,44-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company LLC

US Patent




US Patent US9572802 (2017)


BindingDB Entry DOI: 10.7270/Q2VH5QWS
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103773
PNG
(US8551978, I-43 | US8816088, I-43 | US9394275, I-4...)
Show SMILES C[C@@H](Cc1ccc(NC(=O)c2cccc(c2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r|
Show InChI InChI=1S/C49H52N6O7/c1-32(50-31-44(57)40-19-21-43(56)47-41(40)20-22-45(58)53-47)29-33-15-17-36(18-16-33)51-48(60)35-11-8-12-37(30-35)54(2)46(59)25-28-55-26-23-38(24-27-55)62-49(61)52-42-14-7-6-13-39(42)34-9-4-3-5-10-34/h3-22,30,32,38,44,50,56-57H,23-29,31H2,1-2H3,(H,51,60)(H,52,61)(H,53,58)/t32-,44-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company LLC

US Patent




US Patent US9572802 (2017)


BindingDB Entry DOI: 10.7270/Q2VH5QWS
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM290168
PNG
(US9572802, Compound I-44)
Show SMILES CC(Cc1cccc(CNC(=O)c2cccc(c2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)c1)NCC(O)c1ccc(O)c2[nH]c(=O)ccc12
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company LLC

US Patent




US Patent US9572802 (2017)


BindingDB Entry DOI: 10.7270/Q2VH5QWS
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103776
PNG
(US8551978, I-46 | US8816088, I-46 | US9394275, I-4...)
Show SMILES CC(Cc1ccc(CNC(=O)c2cccc(c2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r|
Show InChI InChI=1S/C50H54N6O7/c1-33(51-32-45(58)41-19-21-44(57)48-42(41)20-22-46(59)54-48)29-34-15-17-35(18-16-34)31-52-49(61)37-11-8-12-38(30-37)55(2)47(60)25-28-56-26-23-39(24-27-56)63-50(62)53-43-14-7-6-13-40(43)36-9-4-3-5-10-36/h3-22,30,33,39,45,51,57-58H,23-29,31-32H2,1-2H3,(H,52,61)(H,53,62)(H,54,59)/t33?,45-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company LLC

US Patent




US Patent US9572802 (2017)


BindingDB Entry DOI: 10.7270/Q2VH5QWS
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103779
PNG
(US8551978, I-49 | US8816088, I-49 | US9394275, I-4...)
Show SMILES C[C@@H](Cc1ccc(CNC(=O)c2cccc(c2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r|
Show InChI InChI=1S/C50H54N6O7/c1-33(51-32-45(58)41-19-21-44(57)48-42(41)20-22-46(59)54-48)29-34-15-17-35(18-16-34)31-52-49(61)37-11-8-12-38(30-37)55(2)47(60)25-28-56-26-23-39(24-27-56)63-50(62)53-43-14-7-6-13-40(43)36-9-4-3-5-10-36/h3-22,30,33,39,45,51,57-58H,23-29,31-32H2,1-2H3,(H,52,61)(H,53,62)(H,54,59)/t33-,45-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company LLC

US Patent




US Patent US9572802 (2017)


BindingDB Entry DOI: 10.7270/Q2VH5QWS
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103755
PNG
(US8551978, I-23 | US8816088, I-23 | US9394275, I-2...)
Show SMILES C[C@H](Cc1cccc(CC(=O)NCCCCN(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r|
Show InChI InChI=1S/C48H58N6O7/c1-33(50-32-43(56)39-17-19-42(55)47-40(39)18-20-44(57)52-47)29-34-11-10-12-35(30-34)31-45(58)49-24-8-9-25-53(2)46(59)23-28-54-26-21-37(22-27-54)61-48(60)51-41-16-7-6-15-38(41)36-13-4-3-5-14-36/h3-7,10-20,30,33,37,43,50,55-56H,8-9,21-29,31-32H2,1-2H3,(H,49,58)(H,51,60)(H,52,57)/t33-,43+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company, LLC

US Patent


Assay Description
Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 μL. CHO ce...


US Patent US9682957 (2017)


BindingDB Entry DOI: 10.7270/Q23776WR
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103756
PNG
(US8551978, I-24 | US8816088, I-24 | US9394275, I-2...)
Show SMILES C[C@@H](Cc1cccc(CC(=O)NCCCCN(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r|
Show InChI InChI=1S/C48H58N6O7/c1-33(50-32-43(56)39-17-19-42(55)47-40(39)18-20-44(57)52-47)29-34-11-10-12-35(30-34)31-45(58)49-24-8-9-25-53(2)46(59)23-28-54-26-21-37(22-27-54)61-48(60)51-41-16-7-6-15-38(41)36-13-4-3-5-14-36/h3-7,10-20,30,33,37,43,50,55-56H,8-9,21-29,31-32H2,1-2H3,(H,49,58)(H,51,60)(H,52,57)/t33-,43-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company, LLC

US Patent


Assay Description
Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 μL. CHO ce...


US Patent US9682957 (2017)


BindingDB Entry DOI: 10.7270/Q23776WR
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM6427
PNG
(US8551978, I-25 | US8816088, 25 | US9572802, Compo...)
Show SMILES CN(C(=O)CCN1CCC(CC1)OC(=O)Nc1ccccc1-c1ccccc1)c1cccc(c1)C(=O)Nc1ccc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1 |r|
Show InChI InChI=1S/C47H48N6O7/c1-52(44(57)24-27-53-25-22-36(23-26-53)60-47(59)50-40-13-6-5-12-37(40)32-8-3-2-4-9-32)35-11-7-10-33(28-35)46(58)49-34-16-14-31(15-17-34)29-48-30-42(55)38-18-20-41(54)45-39(38)19-21-43(56)51-45/h2-21,28,36,42,48,54-55H,22-27,29-30H2,1H3,(H,49,58)(H,50,59)(H,51,56)/t42-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company, LLC

US Patent


Assay Description
Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 μL. CHO ce...


US Patent US9682957 (2017)


BindingDB Entry DOI: 10.7270/Q23776WR
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103758
PNG
(US8551978, I-27 | US8816088, I-27 | US9394275, I-2...)
Show SMILES CN(C(=O)CCN1CCC(CC1)OC(=O)Nc1ccccc1-c1ccccc1)c1cccc(c1)C(=O)Nc1ccc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1C |r|
Show InChI InChI=1S/C48H50N6O7/c1-31-27-32(29-49-30-43(56)38-16-19-42(55)46-39(38)17-20-44(57)52-46)15-18-40(31)50-47(59)34-11-8-12-35(28-34)53(2)45(58)23-26-54-24-21-36(22-25-54)61-48(60)51-41-14-7-6-13-37(41)33-9-4-3-5-10-33/h3-20,27-28,36,43,49,55-56H,21-26,29-30H2,1-2H3,(H,50,59)(H,51,60)(H,52,57)/t43-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company, LLC

US Patent


Assay Description
Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 μL. CHO ce...


US Patent US9682957 (2017)


BindingDB Entry DOI: 10.7270/Q23776WR
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103760
PNG
(US8551978, I-29 | US8816088, I-29 | US9394275, I-2...)
Show SMILES COc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1NC(=O)c1cccc(c1)N(C)C(=O)CCN1CCC(CC1)OC(=O)Nc1ccccc1-c1ccccc1 |r|
Show InChI InChI=1S/C48H50N6O8/c1-53(45(58)23-26-54-24-21-35(22-25-54)62-48(60)51-39-14-7-6-13-36(39)32-9-4-3-5-10-32)34-12-8-11-33(28-34)47(59)50-40-18-15-31(27-43(40)61-2)29-49-30-42(56)37-16-19-41(55)46-38(37)17-20-44(57)52-46/h3-20,27-28,35,42,49,55-56H,21-26,29-30H2,1-2H3,(H,50,59)(H,51,60)(H,52,57)/t42-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company, LLC

US Patent


Assay Description
Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 μL. CHO ce...


US Patent US9682957 (2017)


BindingDB Entry DOI: 10.7270/Q23776WR
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103763
PNG
(US8551978, I-32 | US8816088, I-32 | US9394275, I-3...)
Show SMILES CN(C(=O)CCN1CCC(CC1)OC(=O)Nc1ccccc1-c1ccccc1)c1cccc(c1)C(=O)Nc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)c1 |r|
Show InChI InChI=1S/C48H50N6O7/c1-53(45(58)24-28-54-26-22-37(23-27-54)61-48(60)51-41-16-6-5-15-38(41)33-10-3-2-4-11-33)36-14-8-12-34(30-36)47(59)50-35-13-7-9-32(29-35)21-25-49-31-43(56)39-17-19-42(55)46-40(39)18-20-44(57)52-46/h2-20,29-30,37,43,49,55-56H,21-28,31H2,1H3,(H,50,59)(H,51,60)(H,52,57)/t43-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company, LLC

US Patent


Assay Description
Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 μL. CHO ce...


US Patent US9682957 (2017)


BindingDB Entry DOI: 10.7270/Q23776WR
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103765
PNG
(US8551978, I-34 | US8816088, I-34 | US9682957, I-3...)
Show SMILES CN(C(=O)CCN1CCC(CC1)OC(=O)Nc1ccccc1-c1ccccc1)c1cccc(c1)C(=O)Nc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1 |r|
Show InChI InChI=1S/C49H52N6O7/c1-32-12-15-35(48(60)51-36-16-13-33(14-17-36)22-26-50-31-44(57)39-18-20-43(56)47-40(39)19-21-45(58)53-47)30-42(32)54(2)46(59)25-29-55-27-23-37(24-28-55)62-49(61)52-41-11-7-6-10-38(41)34-8-4-3-5-9-34/h3-21,30,37,44,50,56-57H,22-29,31H2,1-2H3,(H,51,60)(H,52,61)(H,53,58)/t44-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company, LLC

US Patent


Assay Description
Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 μL. CHO ce...


US Patent US9682957 (2017)


BindingDB Entry DOI: 10.7270/Q23776WR
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103770
PNG
(US8551978, I-40 | US8816088, I-40 | US9394275, I-4...)
Show SMILES CC(Cc1ccc(NC(=O)c2cccc(c2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r|
Show InChI InChI=1S/C49H52N6O7/c1-32(50-31-44(57)40-19-21-43(56)47-41(40)20-22-45(58)53-47)29-33-15-17-36(18-16-33)51-48(60)35-11-8-12-37(30-35)54(2)46(59)25-28-55-26-23-38(24-27-55)62-49(61)52-42-14-7-6-13-39(42)34-9-4-3-5-10-34/h3-22,30,32,38,44,50,56-57H,23-29,31H2,1-2H3,(H,51,60)(H,52,61)(H,53,58)/t32?,44-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company, LLC

US Patent


Assay Description
Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 μL. CHO ce...


US Patent US9682957 (2017)


BindingDB Entry DOI: 10.7270/Q23776WR
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103773
PNG
(US8551978, I-43 | US8816088, I-43 | US9394275, I-4...)
Show SMILES C[C@@H](Cc1ccc(NC(=O)c2cccc(c2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r|
Show InChI InChI=1S/C49H52N6O7/c1-32(50-31-44(57)40-19-21-43(56)47-41(40)20-22-45(58)53-47)29-33-15-17-36(18-16-33)51-48(60)35-11-8-12-37(30-35)54(2)46(59)25-28-55-26-23-38(24-27-55)62-49(61)52-42-14-7-6-13-39(42)34-9-4-3-5-10-34/h3-22,30,32,38,44,50,56-57H,23-29,31H2,1-2H3,(H,51,60)(H,52,61)(H,53,58)/t32-,44-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company, LLC

US Patent


Assay Description
Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 μL. CHO ce...


US Patent US9682957 (2017)


BindingDB Entry DOI: 10.7270/Q23776WR
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103774
PNG
(US8551978, I-44 | US8816088, I-44 | US9394275, I-4...)
Show SMILES CC(Cc1cccc(CNC(=O)c2cccc(c2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r|
Show InChI InChI=1S/C50H54N6O7/c1-33(51-32-45(58)41-18-20-44(57)48-42(41)19-21-46(59)54-48)28-34-10-8-11-35(29-34)31-52-49(61)37-14-9-15-38(30-37)55(2)47(60)24-27-56-25-22-39(23-26-56)63-50(62)53-43-17-7-6-16-40(43)36-12-4-3-5-13-36/h3-21,29-30,33,39,45,51,57-58H,22-28,31-32H2,1-2H3,(H,52,61)(H,53,62)(H,54,59)/t33?,45-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company, LLC

US Patent


Assay Description
Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 μL. CHO ce...


US Patent US9682957 (2017)


BindingDB Entry DOI: 10.7270/Q23776WR
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103776
PNG
(US8551978, I-46 | US8816088, I-46 | US9394275, I-4...)
Show SMILES CC(Cc1ccc(CNC(=O)c2cccc(c2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r|
Show InChI InChI=1S/C50H54N6O7/c1-33(51-32-45(58)41-19-21-44(57)48-42(41)20-22-46(59)54-48)29-34-15-17-35(18-16-34)31-52-49(61)37-11-8-12-38(30-37)55(2)47(60)25-28-56-26-23-39(24-27-56)63-50(62)53-43-14-7-6-13-40(43)36-9-4-3-5-10-36/h3-22,30,33,39,45,51,57-58H,23-29,31-32H2,1-2H3,(H,52,61)(H,53,62)(H,54,59)/t33?,45-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company, LLC

US Patent


Assay Description
Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 μL. CHO ce...


US Patent US9682957 (2017)


BindingDB Entry DOI: 10.7270/Q23776WR
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103779
PNG
(US8551978, I-49 | US8816088, I-49 | US9394275, I-4...)
Show SMILES C[C@@H](Cc1ccc(CNC(=O)c2cccc(c2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r|
Show InChI InChI=1S/C50H54N6O7/c1-33(51-32-45(58)41-19-21-44(57)48-42(41)20-22-46(59)54-48)29-34-15-17-35(18-16-34)31-52-49(61)37-11-8-12-38(30-37)55(2)47(60)25-28-56-26-23-39(24-27-56)63-50(62)53-43-14-7-6-13-40(43)36-9-4-3-5-10-36/h3-22,30,33,39,45,51,57-58H,23-29,31-32H2,1-2H3,(H,52,61)(H,53,62)(H,54,59)/t33-,45-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company, LLC

US Patent


Assay Description
Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 μL. CHO ce...


US Patent US9682957 (2017)


BindingDB Entry DOI: 10.7270/Q23776WR
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103783
PNG
(US8551978, I-53 | US8816088, I-53 | US9572802, Com...)
Show SMILES CC(Cc1ccc(CC(=O)Nc2cccc(c2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r|
Show InChI InChI=1S/C50H54N6O7/c1-33(51-32-45(58)41-19-21-44(57)49-42(41)20-22-46(59)54-49)29-34-15-17-35(18-16-34)30-47(60)52-37-11-8-12-38(31-37)55(2)48(61)25-28-56-26-23-39(24-27-56)63-50(62)53-43-14-7-6-13-40(43)36-9-4-3-5-10-36/h3-22,31,33,39,45,51,57-58H,23-30,32H2,1-2H3,(H,52,60)(H,53,62)(H,54,59)/t33?,45-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company, LLC

US Patent


Assay Description
Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 μL. CHO ce...


US Patent US9682957 (2017)


BindingDB Entry DOI: 10.7270/Q23776WR
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103787
PNG
(US8551978, I-57 | US8816088, I-57 | US9682957, I-5...)
Show SMILES C[C@H](Cc1ccc(CCNC(=O)c2ccc(cc2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r|
Show InChI InChI=1S/C51H56N6O7/c1-34(53-33-46(59)42-20-22-45(58)49-43(42)21-23-47(60)55-49)32-36-14-12-35(13-15-36)24-28-52-50(62)38-16-18-39(19-17-38)56(2)48(61)27-31-57-29-25-40(26-30-57)64-51(63)54-44-11-7-6-10-41(44)37-8-4-3-5-9-37/h3-23,34,40,46,53,58-59H,24-33H2,1-2H3,(H,52,62)(H,54,63)(H,55,60)/t34-,46+/m1/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company, LLC

US Patent


Assay Description
Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 μL. CHO ce...


US Patent US9682957 (2017)


BindingDB Entry DOI: 10.7270/Q23776WR
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103789
PNG
(US8551978, I-59 | US8816088, I-59 | US9394275, I-5...)
Show SMILES CN(C(=O)CCN1CCC(CC1)OC(=O)Nc1ccccc1-c1ccccc1)c1cccc(CC(=O)Nc2ccc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)c1 |r|
Show InChI InChI=1S/C48H50N6O7/c1-53(46(59)24-27-54-25-22-37(23-26-54)61-48(60)51-41-13-6-5-12-38(41)34-9-3-2-4-10-34)36-11-7-8-33(28-36)29-45(58)50-35-16-14-32(15-17-35)30-49-31-43(56)39-18-20-42(55)47-40(39)19-21-44(57)52-47/h2-21,28,37,43,49,55-56H,22-27,29-31H2,1H3,(H,50,58)(H,51,60)(H,52,57)/t43-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company, LLC

US Patent


Assay Description
Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 μL. CHO ce...


US Patent US9682957 (2017)


BindingDB Entry DOI: 10.7270/Q23776WR
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103790
PNG
(US8551978, I-60 | US8816088, I-60 | US9394275, I-6...)
Show SMILES CN(C(=O)CCN1CCC(CC1)OC(=O)Nc1ccccc1-c1ccccc1)c1cccc(CC(=O)Nc2cc(C)c(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2C)c1 |r|
Show InChI InChI=1S/C50H54N6O7/c1-32-27-43(33(2)26-36(32)30-51-31-45(58)40-16-18-44(57)49-41(40)17-19-46(59)54-49)52-47(60)29-34-10-9-13-37(28-34)55(3)48(61)22-25-56-23-20-38(21-24-56)63-50(62)53-42-15-8-7-14-39(42)35-11-5-4-6-12-35/h4-19,26-28,38,45,51,57-58H,20-25,29-31H2,1-3H3,(H,52,60)(H,53,62)(H,54,59)/t45-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
0.100n/an/an/an/an/an/an/an/a



Theravance Respiratory Company, LLC

US Patent


Assay Description
Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 μL. CHO ce...


US Patent US9682957 (2017)


BindingDB Entry DOI: 10.7270/Q23776WR
More data for this
Ligand-Target Pair
Displayed 1 to 50 (of 1101 total )  |  Next  |  Last  >>
Jump to: